Full Text View
Tabular View
No Study Results Posted
Related Studies
Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
This study is ongoing, but not recruiting participants.
Study NCT01247571   Information provided by National Cancer Institute (NCI)

First Received on November 23, 2010.   Last Updated on March 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Recurrent Uterine Sarcoma
Uterine Carcinosarcoma
Additional conditions recognized in this trial
Carcinosarcoma
Mixed Tumor, Mullerian
Sarcoma
Uterine Neoplasms
More general conditions related to this trial
Genital Diseases, Female
Genital Neoplasms, Female
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Complex and Mixed
Neoplasms, Connective and Soft Tissue
Urogenital Neoplasms
Uterine Diseases
Interventions listed in this trial
pazopanib hydrochloride
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services